Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Receivables - NetReceivables - Other
Ratios

China SXT Pharmaceuticals (SXTC) Loans and Notes Receivables (2018 - 2022)

China SXT Pharmaceuticals has reported Loans and Notes Receivables over the past 4 years, most recently at $35509.0 for Q1 2022.

  • For Q1 2022, Loans and Notes Receivables changed N/A year-over-year to $35509.0; the TTM value through Mar 2022 reached $35509.0, changed N/A, while the annual FY2022 figure was $35509.0, N/A changed from the prior year.
  • Loans and Notes Receivables for Q1 2022 was $35509.0 at China SXT Pharmaceuticals, up from $17744.0 in the prior quarter.
  • Over five years, Loans and Notes Receivables peaked at $303379.0 in Q1 2018 and troughed at $17744.0 in Q1 2020.
  • A 4-year average of $106247.6 and a median of $81265.0 in 2019 define the central range for Loans and Notes Receivables.
  • Biggest five-year swings in Loans and Notes Receivables: plummeted 73.21% in 2019 and later plummeted 78.17% in 2020.
  • Year by year, Loans and Notes Receivables stood at $93341.0 in 2018, then decreased by 12.94% to $81265.0 in 2019, then plummeted by 78.17% to $17744.0 in 2020, then soared by 100.12% to $35509.0 in 2022.
  • Business Quant data shows Loans and Notes Receivables for SXTC at $35509.0 in Q1 2022, $17744.0 in Q1 2020, and $81265.0 in Q1 2019.